Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma

Table 2 Estimated Marginal Means and UNIANOVA Test of Apinectin, oxLDL, oxLDL-ab, oxLDL-lgG, and oxLDL-lgM in Four Groups^a

	ADP	oxLDL	oxLDL-ab	oxLDL-lgG	oxLDL-lgM
ESSC group	11.699 ± 2.715	25.436 ± 1.951	28.123 ± 3.124	13.378 ± 1.214	26.519 ± 1.073
Dysplasia group	13.980 ± 1.867	30.130 ± 1.675	32.101 ± 2.681	15.645 ± 1.065	24.380 ± 0.921
Basal cell hyperplasia group	11.903 ± 2.202	26.629 ± 1.976	37.367 ± 3.164	15.553 ± 1.257	22.989 ± 1.087
Control group	11.614 ± 2.363	32.790 ± 2.120	38.742 ± 3.395	12.656 ± 1.349	21.329 ± 1.166
F test	0.332	2.739	2.098	1.445	3.503
P	0.802	0.045	0.103	0.232	0.017
Trend test^b	1.518	9.421	10.412	2.789	17.137
P	0.218	0.002	0.001	0.095	0.000

Abbreviations: TC, total cholesterol; TG, triglyceride; ADP, adiponectin; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; oxLDL, oxidized low-density lipoprotein; oxLDL-lgG, immunoglobulin G type of autoantibodies to oxidized low-density lipoprotein; oxLDL-lgM, immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein.
^a Means (SE) for estimated marginal means; Covariates appearing in the model are evaluated at the following values: TG = 3.2961, LDL = 2.2317, HDL = 0.7992, Albumin = 40.2234, age = 54.55.
^b Linear --by --linear association test.

ISSN: 1476-511X